Season 2, Episode 19: Confronting Osteoporosis with Miranda Toledano
Welcome back to the Pharmaverse Podcast, hosted by Michael Pietrack. In this episode, we sit down with Miranda Toledano, CEO of EnteraBio (NASDAQ: ENTX), to explore:
๐น The evolving treatment paradigm for osteoporosis
๐น Why millions of women worldwide remain undiagnosed and untreated
๐น EnteraBioโs groundbreaking EV613 oral tabletโa potential game-changer versus injectables
๐น The FDA alignment milestone using Bone Mineral Density (BMD) as a primary endpoint
๐น Leadership lessons from Mirandaโs Type A+++ drive, balance, and building passionate teams
๐น Career advice for young leaders: โJust keep going.โ
If youโre a leader, innovator, or aspiring professional in biotech, Pharma, or life sciences, this episode is packed with powerful insights that can transform your career.
๐ Donโt forget to like, comment, and subscribe for more thought leadership conversations in the Pharma universe!
๐๐๐๐๐๐๐ ๐๐๐๐ ๐๐:
โถย Website: [https://www.kbic.com/recruiting/]
โถย LinkedIn: [ https://www.linkedin.com/in/michaelpietrack]
โถ Have you seen all of our playlists?ย ย ย ย ย ย ย ย ย [https://www.youtube.com/@ThePharmaversePodcast/playlists ]
โถ Also, join the private LinkedIn Job Board: MSL Job Board
